Dimensional Fund Advisors LP Trims Holdings in Danaher Corporation $DHR

Key Points

• Dimensional Fund Advisors LP reduced its stake in Danaher Corporation by 5.4%, now owning approximately 2.64 million shares valued at $541.48 million.
• Several hedge funds have made significant changes to their positions, including GHP Investment Advisors Inc. increasing its ownership by 396% in the first quarter.
• Analysts have varying outlooks on Danaher, with target prices ranging from $226.00 to $275.00 and an overall consensus rating of "Moderate Buy."

Dimensional Fund Advisors LP lessened its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 5.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,641,415 shares of the conglomerate's stock after selling 150,593 shares during the quarter. Dimensional Fund Advisors LP owned about 0.37% of Danaher worth $541,480,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Bank Pictet & Cie Europe AG grew its position in Danaher by 22.8% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate's stock worth $44,241,000 after purchasing an additional 35,730 shares during the period. CreativeOne Wealth LLC boosted its stake in shares of Danaher by 16.1% in the fourth quarter. CreativeOne Wealth LLC now owns 1,790 shares of the conglomerate's stock worth $411,000 after buying an additional 248 shares during the last quarter. XTX Topco Ltd acquired a new stake in Danaher during the fourth quarter worth about $420,000. Guggenheim Capital LLC grew its holdings in Danaher by 4.5% during the fourth quarter. Guggenheim Capital LLC now owns 25,112 shares of the conglomerate's stock worth $5,764,000 after acquiring an additional 1,090 shares during the period. Finally, NewEdge Advisors LLC raised its position in Danaher by 7.8% during the fourth quarter. NewEdge Advisors LLC now owns 56,790 shares of the conglomerate's stock valued at $13,036,000 after acquiring an additional 4,129 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have commented on DHR shares. Wells Fargo & Company lowered their price objective on Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 23rd. Robert W. Baird boosted their target price on shares of Danaher from $225.00 to $226.00 and gave the company an "outperform" rating in a research note on Friday, July 18th. Royal Bank Of Canada reissued an "outperform" rating and set a $250.00 price target on shares of Danaher in a report on Wednesday, April 23rd. Leerink Partners lifted their price objective on shares of Danaher from $225.00 to $230.00 and gave the company an "outperform" rating in a report on Wednesday, April 23rd. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research report on Tuesday, April 22nd. Seventeen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $247.61.

Danaher Price Performance

Shares of DHR traded down $0.9530 during trading hours on Wednesday, hitting $211.2470. 3,302,498 shares of the stock were exchanged, compared to its average volume of 4,344,760. The stock's 50-day moving average price is $200.46 and its two-hundred day moving average price is $199.62. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The company has a market cap of $151.26 billion, a price-to-earnings ratio of 44.95, a price-to-earnings-growth ratio of 2.96 and a beta of 0.73.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same quarter last year, the firm posted $1.72 EPS. The firm's revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.